Chester Chae

Chester Chae is an experienced regulatory affairs professional currently serving as the Manager of Regulatory Affairs at ORIC Pharmaceuticals Inc. since March 2022. Chester has also been actively involved with the PDA - Parenteral Drug Association as a member of the SoCal PDA Young Professional Committee since July 2020. Previous roles include Manager of Regulatory Affairs at Sorrento Therapeutics, Inc. and Senior Associate in CMC Regulatory Affairs at Amgen. Additional expertise includes consulting on injector devices at BioMarin Pharmaceutical Inc. and project management in a diabetes program at Pomona Valley Hospital Medical Center. Chester holds a Bachelor's degree in Chemistry from Hanover College and a Master's degree in Biotechnology from Keck Graduate Institute, with international experience from University of Wollongong.